Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for MYnd Analytics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in MYnd Analytics. This rating has held steady since July 2020, when it changed from a Buy consensus rating.
MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company manages the delivery of telepsychiatry and telebehavioral health services through a network of psychiatrists, psychologists, and therapists. The company is commercializing its psychiatric electroencephalogram (EEG) evaluation registry predictive analytics tool to help physicians reduce trial and error treatment in mental health. Its technology platform utilizes complex algorithms to analyze EEGs to generate psychiatric EEG evaluation registry reports to predict individual responses to a range of medications prescribed for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder sand other non-psychotic disorders. The company was formerly known as CNS Response, Inc. and changed its name to MYnd Analytics, Inc. in November 2015. MYnd Analytics, Inc. was founded in 2000 and is headquartered in Mission Viejo, California.